Neostigmine Methylsulfate Injection
Product Images NDC 0641-6150

5 FDA label images from Hikma Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Neostigmine Methylsulfate (NDC 0641-6150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Neostigmine Methylsulfate Injection Anda 1)

Structure (Neostigmine Methylsulfate Injection   Anda 1)
Chemical structure of Neostigmine Methylsulfate showing the molecular arrangement including a quaternary ammonium group, benzene ring with methoxy substituent, and methylcarbamate functional group associated with the active ingredient.*
FDA Label Image

5 mg-10 mL Vial (Neostigmine Methylsulfate Injection Anda 2)

5 mg-10 mL Vial (Neostigmine Methylsulfate Injection   Anda 2)
Neostigmine Methylsulfate Injection, USP 5 mg per 10 mL (0.5 mg/mL) in a 10 mL multiple dose vial for intravenous use. The label includes active ingredient details, preservative information, storage instructions at controlled room temperature, and manufacturer Hikma Pharmaceuticals USA Inc.*
FDA Label Image

Shelfpack (Neostigmine Methylsulfate Injection Anda 3)

Shelfpack (Neostigmine Methylsulfate Injection   Anda 3)
Neostigmine Methylsulfate Injection, USP 0.5 mg/mL (5 mg per 10 mL) multiple dose vials. The label indicates the product is for intravenous use, with 10 x 10 mL vials in the package. It includes ingredients, storage instructions, and is manufactured by Hikma Pharmaceuticals USA Inc.*
FDA Label Image

10 mg-10 mL Vial (Neostigmine Methylsulfate Injection Anda 4)

10 mg-10 mL Vial (Neostigmine Methylsulfate Injection   Anda 4)
Neostigmine Methylsulfate Injection, USP 5 mg per 10 mL (0.5 mg/mL) in a multi-dose vial. Label shows active ingredient and concentration, indicated for intravenous use, with storage instructions and manufacturer information for Hikma Pharmaceuticals USA Inc.*
FDA Label Image

Shelfpack (Neostigmine Methylsulfate Injection Anda 5)

Shelfpack (Neostigmine Methylsulfate Injection   Anda 5)
Label for Neostigmine Methylsulfate Injection, USP, 10 mg per 10 mL (1 mg/mL) intravenous injection by Hikma Pharmaceuticals USA Inc. The label includes dosage strength, usage route, preservative and ingredient details, storage instructions, and manufacturer information. It states this is a 10 mL multiple dose vial.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.